{"id":31678,"date":"2022-07-05T08:45:42","date_gmt":"2022-07-05T07:45:42","guid":{"rendered":"https:\/\/touchendocrinology.com\/?post_type=media_gallery&p=31678"},"modified":"2022-07-05T08:45:42","modified_gmt":"2022-07-05T07:45:42","slug":"hertzel-gerstein-ada-2022-risk-factors-for-cardiovascular-disease-in-patients-with-type-2-diabetes","status":"publish","type":"media_gallery","link":"https:\/\/touchendocrinology.com\/cardiovascular-risk\/conference-hub\/hertzel-gerstein-ada-2022-risk-factors-for-cardiovascular-disease-in-patients-with-type-2-diabetes\/","title":{"rendered":"Hertzel Gerstein, ADA 2022: Risk factors for cardiovascular disease in patients with type 2 diabetes"},"content":{"rendered":"

The clinical risk factors for cardiovascular disease in patients with type 2 diabetes and the link between the two is discussed by<\/span> Professor Hertzel Gerstein <\/b>(McMaster University, Hamilton, ON, Canada).<\/span><\/p>\n

Professor Hertzel Gerstein presented an abstract entitled \u2018<\/span>Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome\u2014The ELIXA Biomarker Study<\/span><\/a>\u2018<\/span> at the<\/span> 82nd American Diabetes Association Scientific Session,<\/span><\/a> June 3-7, 2022.<\/span><\/p>\n

Questions<\/strong>:\u00a0<\/span><\/p>\n

    \n
  1. Please can you outline the link between type 2 diabetes and cardiovascular disease? (0:25)<\/span><\/li>\n
  2. What clinical risk factors for cardiovascular disease have already been identified in patients with diabetes and acute coronary syndrome? (1:09)<\/span><\/li>\n<\/ol>\n

    Disclosures<\/strong>: Hertzel Gerstein is on the advisory board and a consultant for Sanofi. Hertzel Gerstein has received grant\/research support and honorarium from Sanofi.<\/span><\/p>\n

    Support<\/strong>: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.<\/span><\/p>\n

    Filmed as a highlight of ADA 2022.<\/a><\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

    The clinical risk factors for cardiovascular disease in patients with type 2 diabetes and the link between the two is discussed by Professor Hertzel Gerstein (McMaster University, Hamilton, ON, Canada). Professor Hertzel Gerstein presented an abstract entitled \u2018Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome\u2014The ELIXA Biomarker Study\u2018 at the 82nd […]<\/p>\n","protected":false},"featured_media":31534,"template":"","class_list":["post-31678","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-cardiovascular-risk","vocabulary_1-diabetes","video_categories-ada-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media_gallery\/31678"}],"collection":[{"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":2,"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media_gallery\/31678\/revisions"}],"predecessor-version":[{"id":31680,"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media_gallery\/31678\/revisions\/31680"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media\/31534"}],"wp:attachment":[{"href":"https:\/\/touchendocrinology.com\/wp-json\/wp\/v2\/media?parent=31678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}